-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
TheraDiag
Identification
Nome strumento
THERADIAG
Ticker
ALTER
Codice ISIN
FR0004197747
Mercato
Euronext Growth
Borsa
Paris
Products family
Stocks
Market organization
Alternext
ICB
Biotechnology
Activity description
TheraDiag (ex Biomedical Diagnostics) est spécialisé dans le développement, la fabrication et la commercialisation de kits de diagnostics in-vitro destinés à la détection des maladies auto-immunes, des allergies et des maladies infectieuses. En outre, le groupe propose des tests de théranostic dédiés à monitorer les biothérapies et à déterminer la réponse des patients aux traitements reçus.
Source Cofisem
Indirizzo web
http://www.theradiag.com
Operation
Data IPO
Mar 11/12/2012
Tipologia IPO
Introduction par offre au public
Tipologia IPO
Initial Public offering
Categoria
IPO
Calendario
Listing date: 05/12/2012
First trading date: 11/12/2012
Intervallo di prezzo
Fourchette de prix indicative : 4,80 EUR - 5,80 EUR